PASADENA – The World Stem Cell Summit, now in its seventh year, will kick off three days of networking and seminars on Monday at the Pasadena Convention Center in hopes of spurring progress and investment in the emerging industry. The event promises more than 150 top international speakers and 50 hours of programming with industry leaders from science, pharmaceuticals, business, policy, ethics, law and more. Bernie Siegel, founder and co-chair of the Summit and executive director the Genetic Policy Institute (GPI), which produces the event, said this year’s focus on translational regenerative medicine is about asking “how do you take the phenomenal scientific research going on in labs and translate it into medical treatments? It’s a big job to do this, and more than just the science.”
Recent Posts
- Newly discovered mechanism in the cell’s energy factory can lead to new treatment of muscle disorders
- New drug tested to reduce side effect of ‘half-matched’ stem cell transplants
- Gene and Cell Therapies Take Aim at Parkinson’s Disease
- Health Net grant for UC Davis Stem Cell Program to improve access to CAR T-cell therapy
- Stem cell therapy TED-A9 showing safety and early efficacy in trial
- High Response Rate for CAR T-Cell Therapy in Patients With Fast-Growing Leukemia